Eurolide Depot 3.75mg Injection

About

Eurolide Depot 3.75mg Injection contains Leuprolide, a synthetic gonadotropin-releasing hormone (GnRH) agonist. It works by initially stimulating and then desensitizing the GnRH receptors in the pituitary gland, leading to a profound suppression of gonadotropin release (luteinizing hormone and follicle-stimulating hormone). This suppression ultimately results in a significant reduction in the production of sex hormones, such as testosterone in males and estrogen in females. The depot formulation ensures a sustained release of the medication over an extended period, typically one month, providing continuous hormonal suppression.

This medication is primarily used in the management of hormone-sensitive conditions. In men, it is indicated for the palliative treatment of advanced prostate cancer. In women, it is used to manage endometriosis and uterine fibroids, where estrogen suppression can alleviate symptoms and reduce lesion size. It is also employed in children for the treatment of central precocious puberty, by suppressing premature sexual development. Its long-acting nature makes it a convenient and effective therapeutic option for chronic conditions requiring sustained hormonal blockade.

Uses

• Palliative treatment of advanced prostate cancer.
• Management of endometriosis.
• Treatment of uterine fibroids.
• Management of central precocious puberty.

Directions For Use

Eurolide Depot 3.75mg Injection is administered subcutaneously or intramuscularly by a healthcare professional, typically once every month. Follow your doctor's schedule precisely.

Benefits

• Provides sustained hormonal suppression.
• Effective in managing prostate cancer.
• Alleviates symptoms of endometriosis.
• Reduces size of uterine fibroids.
• Controls central precocious puberty.
• Offers convenient monthly dosing.

Side Effects

• Hot flashes
• Sweating
• Fatigue
• Headache
• Nausea/vomiting
• Injection site reactions
• Bone pain (initial flare)
• Decreased libido
• Erectile dysfunction (men)
• Vaginal dryness (women)
• Mood changes
• Weight changes

Safety Measures

• Alcohol - No specific contraindication with alcohol, but moderation is generally advised.
• Pregnancy - Eurolide is contraindicated in pregnancy due to the risk of fetal harm. Effective non-hormonal contraception should be used.
• Breastfeeding - Not recommended during breastfeeding as it may interfere with lactation and potentially harm the infant.
• Liver - Use with caution in patients with liver impairment; however, significant dose adjustment is generally not required.
• Kidney - No specific dose adjustment is typically needed for patients with renal impairment.
• Lung - No specific lung-related safety concerns are commonly associated with Leuprolide.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.